GASTRO-PRA
Despite the declining incidence, gastric cancer (GC) remains the second leading cause of
cancer death worldwide. In France, it is the second digestive cancer with 7,000 new cases per
year. It is now well demonstrated that patients with H. pylori infection, atrophic gastritis
and intestinal metaplasia, have a high risk of developing GC. It is therefore important to
detect these pre-neoplastic lesions at an early stage to improve patients prognosis. Thus, the aim of this project is to investigate the possible screening of gastric
precancerous lesions by a blood test (GastroPanel®) in France, in patients with
oesophagogastroduodenoscopy (EGD) prescription.
Apr 30,2016
All
18 Years
N/A
18 Years
N/A
2000